0001209191-18-017709.txt : 20180307 0001209191-18-017709.hdr.sgml : 20180307 20180307161645 ACCESSION NUMBER: 0001209191-18-017709 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180305 FILED AS OF DATE: 20180307 DATE AS OF CHANGE: 20180307 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gano Kyle CENTRAL INDEX KEY: 0001567160 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-22705 FILM NUMBER: 18673570 MAIL ADDRESS: STREET 1: NEUROCRINE BIOSCIENCES, INC. STREET 2: 12780 EL CAMINO REAL CITY: SAN DIEGO STATE: CA ZIP: 92130 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NEUROCRINE BIOSCIENCES INC CENTRAL INDEX KEY: 0000914475 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 330525145 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12780 EL CAMINO REAL CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (858) 617-7600 MAIL ADDRESS: STREET 1: 12780 EL CAMINO REAL CITY: SAN DIEGO STATE: CA ZIP: 92130 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-03-05 0 0000914475 NEUROCRINE BIOSCIENCES INC NBIX 0001567160 Gano Kyle 12780 EL CAMINO REAL SAN DIEGO CA 92130 0 1 0 0 Chief Business Development Off Common Stock 2018-03-05 4 M 0 23650 8.65 A 102392 D Common Stock 2018-03-05 4 S 0 23650 90.00 D 78742 D Non-Qualified Stock Option 8.65 2018-03-05 4 M 0 23650 8.65 A 2023-01-10 Common Stock 23650 0 D The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 90 days prior to the transaction date in Box 2 above. Additionally, Issuer policy restricts the Reporting Person from amending, canceling, suspending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan. Option granted January 10, 2013 and vested monthly over four years. /s/ Darin Lippoldt, Attorney-in-Fact 2018-03-07